ImmunoPrecise Antibodies Ltd.

NasdaqGM:IPA Stock Report

Market Cap: US$17.9m

ImmunoPrecise Antibodies Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:IPA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Dec 24BuyUS$11,616Ingrid BrandsIndividual27,013US$0.43
17 Dec 24BuyUS$105,810Dirk Van HyfteIndividual262,500US$0.43
16 Dec 24BuyUS$95,228Jennifer BathIndividual237,300US$0.42
16 Dec 24BuyUS$94,195Ingrid BrandsIndividual235,487US$0.40
02 Aug 24BuyUS$4,350Barry SpringerIndividual5,000US$0.87
01 Aug 24BuyUS$8,200Kristin TaylorIndividual10,000US$0.82
01 Aug 24BuyUS$8,156Mitchell LevineIndividual10,000US$0.82
01 Aug 24BuyUS$10,008Jennifer BathIndividual12,000US$0.84
27 Mar 24BuyUS$13,892Jennifer BathIndividual9,000US$1.57
26 Mar 24BuyUS$7,650Kristin TaylorIndividual5,000US$1.53
22 Mar 24BuyUS$4,470Jennifer BathIndividual3,000US$1.49
21 Mar 24BuyUS$12,549Jennifer BathIndividual9,000US$1.41
21 Mar 24BuyUS$14,256Mitchell LevineIndividual10,000US$1.43
18 Mar 24BuyUS$8,112Ilse RoodinkIndividual5,600US$1.45

Insider Trading Volume

Insider Buying: IPA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IPA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies8,0450.024%
Institutions1,897,2065.66%
Individual Insiders4,239,94012.6%
General Public27,386,30581.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.4%.

Top Shareholders

Top 25 shareholders own 18.33% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
5.45%
Ingrid Brands
1,828,365US$978.2k16.8%no data
5.45%
Dirk Van Hyfte
1,828,365US$978.2k16.8%no data
4.65%
Ingalls & Snyder, LLC
1,558,892US$834.0k20.3%0.03%
1.49%
Jennifer Bath
498,118US$266.5k91%no data
0.18%
Renaissance Technologies LLC
60,300US$32.3k-5.65%no data
0.17%
BMO Asset Management Corp.
57,807US$30.9k3.49%no data
0.15%
Northern Trust Global Investments
50,730US$27.1k0%no data
0.12%
Canadian Imperial Bank of Commerce, Asset Management Arm
41,200US$22.0k0%no data
0.089%
Mitchell Levine
30,000US$16.1k50%no data
0.08%
Gradient Capital Advisors, LLC
26,808US$14.3k0%no data
0.078%
Fédération des Caisses Desjardins du Québec, Asset Management Arm
26,273US$14.1k-2.81%no data
0.06%
Kristin Taylor
20,000US$10.7k100%no data
0.052%
Geode Capital Management, LLC
17,484US$9.4k0%no data
0.047%
XTX Holdings Limited, Asset Management Arm
15,675US$8.4k23.5%no data
0.045%
Barry Springer
15,000US$8.0k0%no data
0.042%
Rathbones Investment Management Limited
14,000US$7.5k0%no data
0.037%
Morgan Stanley, Investment Banking and Brokerage Investments
12,533US$6.7k19%no data
0.03%
Mariner, LLC
10,000US$5.3k0%no data
0.028%
Ilse Roodink
9,542US$5.1k0%no data
0.026%
Elizabeth Grant
8,600US$4.6k0%no data
0.024%
Republique Capital
8,045US$4.3k0%no data
0.006%
Bank of America Corporation, Asset Management Arm
2,000US$1.1k0%no data
0.0058%
Dirk Witters
1,950US$1.0k0%no data
0.005%
National Bank Investments Inc.
1,671US$893.48.51%no data
0.005%
West Paces Advisors, Inc.
1,665US$891.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 23:54
End of Day Share Price 2025/01/08 00:00
Earnings2024/10/31
Annual Earnings2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ImmunoPrecise Antibodies Ltd. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert WassermanBenchmark Company
Tania Armstrong-WhitworthCormark Securities Inc.
Swayampakula RamakanthH.C. Wainwright & Co.